LunaVax

02/11/2026

One year ago, LunaVax began with a simple question.
Today, we’re laying the foundation for a new vaccine access system in Nigeria.

Read our one-year reflection and what comes next:
https://lunavax.com/lunavax-insights-one-year-later/

12/11/2025

Access shouldn’t depend on needles or distance.
Access is delivery.

Together we vaccinate. Together we thrive.

12/06/2025

Explore the Luna360 Engagement Guide and learn how you can help drive equitable vaccine access across Africa through advocacy, partnerships, and innovation.

11/20/2025

Fact, Fiction, or Future?
Swipe to see what’s fact — and how Microneedle Vaccine Patches (MAPs) could reshape vaccine delivery across Africa.

LunaVax is leading Africa’s first MAP + biometrics pilot in Nigeria.
Join the movement.

11/13/2025

Nigeria has launched Africa’s largest vaccination campaign, aiming to protect nearly 100 million children with life-saving vaccines and treatments. A historic effort and a major step toward stronger immunization systems nationwide.

Read more in our News & Insights: https://lunavax.com/lunavax-insights-nigeria-leads-africas-largest-vaccination-campaign/

Thanks to National Primary Health Care Development Agency and Federal Ministry of Health Nigeria for leading this national effort.

10/17/2025

Nigeria’s 3-Phase MAP Vaccine Roadmap (2025–2030):
A Scalable Model for Equitable Vaccine Access and Local Production

LunaVax is leading Africa’s first pilot combining microneedle vaccine patches (MAPs) with biometric verification, pioneering a new model for vaccine delivery.

Explore the full roadmap: https://lunavax.com/resources-nigeria-map-roadmap-2025-2030/

Download LunaVax and Harvard GCSRT’s roadmap for Nigeria’s first MAP vaccine pilot, integrating biometrics, innovation, and local production.

10/09/2025

Countdown to Impact:
The LunaVax MAP pilot, as part of the Harvard Medical School GCSRT program, has entered the preparatory phase for Nigeria’s first multi-state microneedle vaccine pilot.

Advancing local innovation and equitable vaccine access.

10/02/2025

Africa’s health is at a defining moment. As foreign aid shrinks and systems are tested, leaders and youth are shaping a new vision, calling for more domestic resources and innovative financing to sustain Africa’s health future. The Tipping Point, hosted by The Access Challenge and Global Health Corps, showed that this new era will be led by Africans and powered by innovation.

Together with Africa CDC, the African Union, PATH, and health leaders worldwide, we showed a shared commitment to reimagining health leadership for the continent.

This is the future LunaVax is building with vaccine access solutions made for Africa, by Africa.

09/26/2025

At ’s Health Without Borders convening, leaders highlighted an urgent reality: by 2030, the world could face a shortage of 11 million health workers.

A strong health workforce is also the backbone of immunization. LunaVax is committed to advancing innovations that support health workers and contribute to a more self-reliant vaccine future for Africa.

09/25/2025

At The Tipping Point: A New Era for Global Health Leadership during , hosted by Global Health Corps and The Access Challenge, we joined Africa CDCAfrican Union, PATH, and global partners to reimagine the future of health in Africa.

LunaVax is proud to be part of this movement advancing vaccine equity and health self-reliance across the continent.

09/18/2025

Biometrics that count.
With Simprints and Ghana Health Service, frontline teams are ensuring vaccines reach the child they are meant for. No one missed and no dose wasted. Supported by Arm, Gavi, the Vaccine Alliance, and the Steele Foundation for Hope, Simprints have a goal to reach 500,000 children by the end of 2026.

Read more in our News & Insights: https://lunavax.com/lunavax-insights-biometrics-for-vaccine-equity-in-ghana/

09/16/2025

Spotlight from Luna360: How Ghana is using biometrics to strengthen vaccine equity.